We updated the design of this site on September 25th. Learn more.
Show more
ClinicalTrials.gov
ClinicalTrials.gov Menu

Study of Anti-Viral Prophylaxis for HBsAg(+) or HBcAb(+)/HBsAb(-) Patients Starting Anti-TNFα

This study has been terminated.
(Delayed recruitment, unable to meet calculated sample size)
Sponsor:
ClinicalTrials.gov Identifier:
NCT01694264
First Posted: September 27, 2012
Last Update Posted: March 6, 2017
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
Collaborators:
Konkuk University Medical Center
Kyungpook National University
Kyunghee University Medical Center
Kyung Hee University Hospital at Gangdong
Gachon University Gil Medical Center
Daegu Catholic University Medical Center
Eulji University Hospital
SMG-SNU Boramae Medical Center
The Catholic University of Korea
Severance Hospital
Ajou University School of Medicine
Ewha Womans University Mokdong Hospital
Inha University Hospital
Chonnam National University Hospital
Chonbuk National University Hospital
Chungnam National University Hospital
Hallym University Medical Center
Hanyang University
Dong-A University
Korea University Guro Hospital
Information provided by (Responsible Party):
Yeong-Wook Song, Seoul National University Hospital
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study has been terminated.
  Study Completion Date: December 31, 2015
  Primary Completion Date: August 31, 2015 (Final data collection date for primary outcome measure)